Abstract:Tuberculosis is a global epidemic caused by pathogenic Mycobacterium tuberculosis (Mtb), which seriously threatens human life. Arylamine N-acetyltransferase 2 (NAT2) is a vital enzyme in the synthesis of Mtb wall, and closely related to the growth of Mtb. Herein, a fluorescence-based recognition tool (BDPN) has been developed for rapid, sensitive, and selective detection of NAT2 activity in Mtb. As well as a visual high-throughput screening approach for NAT2 inhibitors was established based on BDPN, and four active natural compounds derived from Psoraleae Fructus were discovered that exhibited strong inhibitory effect toward NAT2. Further-more, Isobavachalcone exhibited the considerable anti-tuberculosis effect through prominently destroying the bacterial cell wall of Mtb and slow down its growth. Moreover, Isobavachalcone could delay the elimination of the anti-tuberculosis drug Isoniazid (INH) mediated by NAT2 and enhance anti-tuberculosis effect of INH. In summary, BDPN was a promising tool for monitoring endogenous NAT2 in Mtb and provided some useful guidance for the rational administration of anti-tuberculosis drug.

Correction: A highly selective fluorescent probe for real-time imaging of bacterial NAT2 and high-throughput screening of natural inhibitors for tuberculosis therapy

A highly selective fluorescent probe for real-time imaging of bacterial NAT2 and high-throughput screening of natural inhibitors for tuberculosis therapy (vol 3, pg 145, 2019)

Erratum to “The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China”

A Highly Selective Fluorescent Probe for Real-Time Imaging of Bacterial NAT2 and High-Throughput Screening of Natural Inhibitors for Tuberculosis Therapy

Correction: A Highly Selective Ratiometric Fluorescent Probe for the Cascade Detection of Zn2+ and H2PO4 - and Its Application in Living Cell Imaging.

Correction: Corrigendum: Quantitative real-time imaging of glutathione

Correction: Locked Nucleic Acid Probe-Based Real-Time PCR Assay for the Rapid Detection of Rifampin-Resistant Mycobacterium Tuberculosis

Correction: A Molecularly Imprinted Antibiotic Receptor on Magnetic Nanotubes for the Detection and Removal of Environmental Oxytetracycline

Correction: A Versatile Two-Photon Fluorescent Probe for Ratiometric Imaging E. Coli Β-Galactosidase in Live Cells and in Vivo

Fluorescence-based Visual Analysis and Inhibitor Screening of Arylamine N-acetyltransferase 2, a Key Enzyme for Tuberculosis

Correction: A Biocompatible Two-Photon Absorbing Fluorescent Mitochondrial Probe for Deep in Vivo Bioimaging

Correction: A Bright NIR-II Fluorescent Probe for Breast Carcinoma Imaging and Image-Guided Surgery

New Fluorescent Probe for Zn2+ Imaging in Living Cells and Plants

Fluorescent Metabolic Labeling-Based Quick Antibiotic Susceptibility Test for Anaerobic Bacteria

Correction: A light-up fluorescence resonance energy transfer magnetic aptamer-sensor for ultra-sensitive lung cancer exosome detection

Correction: A Smart Tumor-Microenvironment Responsive Nanoprobe for Highly Selective and Efficient Combination Therapy

Correction: A Highly Selective Fluorescent Probe for Human NAD(P)H:quinone Oxidoreductase 1 (hnqo1) Detection and Imaging in Living Tumor Cells.

Correction to "A Mitochondrial-Targeting Near-Infrared Fluorescent Probe for Visualizing and Monitoring Viscosity in Live Cells and Tissues"

Correction: Tobramycin-mediated self-assembly of DNA nanostructures for targeted treatment of Pseudomonas aeruginosa -infected lung inflammation

Correction: A Tumor-Targeting Probe Based on a Mitophagy Process for Live Imaging.

Correction: A Fluorescent Biosensor for Cardiac Biomarker Myoglobin Detection Based on Carbon Dots and Deoxyribonuclease I-aided Target Recycling Signal Amplification